Intracranial hypertension secondary to left transverse sinus stenosis treated with venous sinus stenting: a case report
Abstract
Case Presentation: Dural venous sinus stenosis has been increasingly recognized as an important pathophysiological mechanism in patients with intracranial hypertension, often initially managed as idiopathic intracranial hypertension. In some cases, etiological investigation reveals venous sinus narrowing associated with indirect signs of intracranial hypertension without other identifiable secondary causes. Recognition of this condition is important, as endovascular treatment with venous sinus stenting has emerged as an effective therapeutic option in selected patients.A previously healthy 21-year-old woman, with no comorbidities, body mass index of 23, and no regular medication use, presented with progressive pulsatile headache for approximately one month prior to admission. The headache was predominantly bilateral frontal with occipital radiation and was associated with neck stiffness, transient visual obscurations, decreased visual acuity, and tinnitus. Ophthalmologic evaluation revealed bilateral papilledema grade V on the Frisén scale, with visual acuity of 20/150 in the right eye and 20/600 in the left eye. Lumbar puncture demonstrated an opening pressure of 66 cmH₂O and a closing pressure of 29 cmH₂O, confirming intracranial hypertension. Cerebral vascular imaging showed stenosis of the right transverse sinus associated with narrowing of the left transverse sinus. Cerebral angiography demonstrated a pressure gradient of 6 mmHg across the right transverse sinus. Despite unfavorable anatomy, venous sinus stenting of the right transverse sinus was performed under sedation. Postoperatively, the patient showed resolution of headache and progressive visual improvement. One week later, visual acuity improved to 20/40 in the right eye and 20/200 in the left eye (previously amblyopic), with reduction of papilledema to grade III on the Frisén scale in both eyes. Discussion: Transverse sinus stenosis may significantly contribute to increased intracranial pressure due to impairment of cerebral venous outflow. In recent years, venous sinus stenting has emerged as an effective therapeutic strategy for symptomatic patients, particularly in cases with progressive visual impairment or refractoriness to medical treatment. Several studies have demonstrated significant improvement in headache, reduction of papilledema, and visual recovery following the procedure. The present case highlights the importance of investigating secondary causes of intracranial hypertension and underscores the role of endovascular therapy in the management of carefully selected patients. Final Comments: This case highlights the importance of etiological investigation in patients with intracranial hypertension, particularly in the presence of atypical clinical presentation or progressive visual impairment. Identification of venous sinus stenosis may modify the therapeutic approach, with venous sinus stenting representing an effective strategy for intracranial pressure control and visual preservation in selected patients.